<?xml version='1.0' encoding='utf-8'?>
<regulation prefix="Regulation" num=".01" citation="COMAR 10.28.12.01" title_num="10" subtitle_num="28" chapter_num="12" heading="Definitions.">
  <paragraph num="A.">
    <text>In this chapter, the following terms have the meanings indicated.</text>
  </paragraph>
  <paragraph num="B.">
    <text>Terms Defined.</text>
    <paragraph num="(1)">
      <text>“Adverse drug reaction” means a physical or psychological reaction experienced by a patient which:</text>
      <paragraph num="(a)">
        <text>Results from the administration of diagnostic or therapeutic pharmaceutical agents;</text>
      </paragraph>
      <paragraph num="(b)">
        <text>Poses a threat to the health of the patient; and</text>
      </paragraph>
      <paragraph num="(c)">
        <text>Requires treatment or medical intervention.</text>
      </paragraph>
    </paragraph>
    <paragraph num="(2)">
      <text>“Adverse reaction” means the unintended or unexpected effect of treatment on a patient caused by or resulting from:</text>
      <paragraph num="(a)">
        <text>An adverse drug reaction;</text>
      </paragraph>
      <paragraph num="(b)">
        <text>The removal of a superficial foreign body from the eye; or</text>
      </paragraph>
      <paragraph num="(c)">
        <text>The ordering of a laboratory test.</text>
      </paragraph>
    </paragraph>
    <paragraph num="(3)">
      <text>“Board” means the Board of Examiners in Optometry.</text>
    </paragraph>
    <paragraph num="(4)">
      <text>“Diagnostic pharmaceutical agent (DPA)” means a medication that:</text>
      <paragraph num="(a)">
        <text>Directly or indirectly affects the pupil of the eye as defined in COMAR 10.28.11;</text>
      </paragraph>
      <paragraph num="(b)">
        <text>Directly or indirectly affects the sensitivity of the cornea as defined in COMAR 10.28.11; or</text>
      </paragraph>
      <paragraph num="(c)">
        <text>Stains the ocular surface.</text>
      </paragraph>
    </paragraph>
    <paragraph num="(5)">
      <text>“Ophthalmologist” means a physician who practices in the specialty of ophthalmology and who is licensed by the Maryland Board of Physicians.</text>
    </paragraph>
    <paragraph num="(6)">
      <text>“Primary open angle glaucoma” means glaucomatous changes characterized by:</text>
      <paragraph num="(a)">
        <text>Adult onset;</text>
      </paragraph>
      <paragraph num="(b)">
        <text>The presence of open, normal appearing angles as demonstrated by gonioscopy, and not otherwise explained; and</text>
      </paragraph>
      <paragraph num="(c)">
        <text>One or more of the following:</text>
        <paragraph num="(i)">
          <text>The appearance of optic disc damage or optic nerve fiber layer damage as evidenced by the size or shape of the optic disc cup, thinning or notching of the optic disc rim, progressive changes in the appearance of the optic disc cup, optic disc hemorrhage, or nerve fiber layer defects, seen clinically or via imaging;</text>
        </paragraph>
        <paragraph num="(ii)">
          <text>The presence of abnormalities in the visual field including arcuate defect, nasal step, paracentral scotoma, or general depression, in the absence of other causes or explanations for a visual field defect; or</text>
        </paragraph>
        <paragraph num="(iii)">
          <text>Intraocular pressure that is thought to pose a threat to the health of the optic nerve.</text>
        </paragraph>
      </paragraph>
    </paragraph>
    <paragraph num="(7)">
      <text>“Secretary” means the Secretary of Health.</text>
    </paragraph>
    <paragraph num="(8)">
      <text>“Therapeutic pharmaceutical agent (TPA)” means a medication used for the treatment of a disease or condition of the eye as specified in Health Occupations Article, §11-404.2, Annotated Code of Maryland.</text>
    </paragraph>
    <paragraph num="(9)">
      <text>“Therapeutically certified optometrist” means a licensed optometrist who has fulfilled the requirements of the Board and is certified by the Board to use therapeutic pharmaceutical agents in the practice of optometry and provides therapeutic services to patients in Maryland.</text>
    </paragraph>
    <paragraph num="(10)">
      <text>“TPA record” means the optometrist's documentation of a patient's visit, the result of which involved the prescribing of medication or the performance of a procedure for treatment of a medical eye condition by a therapeutically certified optometrist.</text>
    </paragraph>
    <paragraph num="(11)">
      <text>“Universal precautions” has the meaning stated in COMAR 10.06.01.02B(10).</text>
    </paragraph>
  </paragraph>
</regulation>